Showing results (301-310 of 351) with videos related to

Sort By:
Pageof 36
European Journal of Haematology|February 18, 2014
Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxisSeung-Hwan Shin, Jung-Ho Kim, Young-Woo Jeon, et al.
Molecular Diagnosis & Therapy|July 18, 2020
Analytical and Potential Clinical Performance of Oncomine Myeloid Research Assay for Myeloid NeoplasmsJoonhong Park, Hoon Seok Kim, Jong-Mi Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemiaSeung-Ah Yahng, Jung-Ho Kim, Young-Woo Jeon, et al.
Acta Haematologica|November 22, 2014
Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21)Ki-Seong Eom, Hee-Je Kim, Byung-Sik Cho, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 14, 2017
Practical informativeness of short tandem repeat loci for chimerism analysis in hematopoietic stem cell transplantationEunhee Han, Myungshin Kim, Yonggoo Kim, et al.
European Journal of Haematology|November 2, 2012
Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromesSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.
Haematologica|March 13, 2025
Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trialRichard F Schlenk, Pau Montesinos, Hee-Je Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and CandidatesByung-Sik Cho, Gi-June Min, Sung-Su Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2019
Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host DiseaseSung-Eun Lee, Ji-Young Lim, Da-Bin Ryu, et al.
Transplantation and Cellular Therapy|December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage ChemotherapyAlexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Pageof 36